Arabinogalactan and hyaluronic acid in ophthalmic solution: Experimental effect on xanthine oxidoreductase complex as key player in ocular inflammation (in vitro study)
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Experimental Eye Research
- Vol. 196, 108058
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Arabinogalactan as Active Compound in the Management of Corneal Wounds: In Vitro Toxicity and In Vivo Investigations on RabbitsCurrent Eye Research, 2010
- In vitro modulation of the human gastrointestinal microbial community by plant-derived polysaccharide-rich dietary supplementsInternational Journal of Food Microbiology, 2010
- Effect of Hypotonic 0.4% Hyaluronic Acid Drops in Dry Eye Patients: A Cross-Over StudyCornea, 2008
- Larch Arabinogalactan for Dry Eye Protection and Treatment of Corneal Lesions: Investigations in RabbitsJournal of Ocular Pharmacology and Therapeutics, 2007
- Involvement of Oxygen Free Radicals in Experimental Retinal Ischemia and the Selective Vulnerability of Retinal DamageOphthalmic Research, 2001
- Oxygen free radical damage in the cornea after excimer laser therapyBritish Journal of Ophthalmology, 1997
- A study of the causes of non-compliance by patients prescribed eyedrops.British Journal of Ophthalmology, 1990
- The effect of lactulose, pectin, arabinogalactan and cellulose on the production of organic acids and metabolism of ammonia by intestinal bacteria in a faecal incubation systemBritish Journal of Nutrition, 1990
- Superoxide anion radical as an indirect mediator in ocular inflammatory diseaseCurrent Eye Research, 1984
- Ocular Evaluation of Methylcellulose Vehicle in Albino RabbitsJournal of Pharmaceutical Sciences, 1974